| 2.40 Real-Time Quote |  +0.05 / +2.13%Today’s Change | 1.06 Today|||52-Week Range 4.50 | +8.11% Year-to-Date |
| Previous close | 2.35 |
| Today’s open | 2.38 |
| Day’s range | 2.34 - 2.48 |
| Volume | 569,682 |
| Average volume (3 months) | 718,754 |
| Market cap | $109.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -190.91% |
| Earnings growth (this year) | -55.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.90 |
| Today’s change | Today’s % change | |
|---|---|---|
| NWBONorthwest Biotherape... | -0.03 | -0.81% |
| ATHXAthersys Inc | +0.06 | +3.23% |
| STMLStemline Therapeutic... | +0.05 | +0.34% |
| BOTABiota Pharmaceutical... | +0.13 | +3.59% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.7M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Robert B. Jones, MBA |
CFO, Secretary, SVP-Investor & Media Relations Peter A. Clemens, MBA, CPA |
Corporate headquarters Palatine, Illinois |
.
